Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein)

Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein) Uses, Dosage, Side Effects, Food Interaction and all others data.

Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein) is under investigation in clinical trial NCT03422627 (Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease).

Trade Name Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein)
Generic Efavaleukin alfa
Efavaleukin alfa Other Names Efavaleukin alfa, Fc il-2 mutein fusion protein (amg-592), Immunoglobulin g1 (fc domain-containing fragment) fusion protein with peptide (synthetic linker) fusion protein with interleukin 2 (synthetic human mutein), dimer
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein)
Immunoglobulin G1 (fc Domain-containing Fragment) Fusion Protein With Peptide (synthetic Linker) Fusion Protein With Interleukin 2 (synthetic Human Mutein)

*** Taking medicines without doctor's advice can cause long-term problems.
Share